CAD 0.04
(-20.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 2.05 Million CAD | -3.86% |
2022 | 2.13 Million CAD | 5.46% |
2021 | 2.02 Million CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | -100.0% |
2016 | 190.27 Thousand CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 2 Million CAD | -0.45% |
2023 Q2 | 2.07 Million CAD | -2.54% |
2023 Q3 | 2.06 Million CAD | -0.53% |
2023 Q1 | 2.12 Million CAD | -0.46% |
2023 Q4 | 2.05 Million CAD | -0.36% |
2023 FY | 2.05 Million CAD | -3.86% |
2022 Q2 | 2.04 Million CAD | 1.04% |
2022 Q4 | 2.13 Million CAD | 0.08% |
2022 Q1 | 2.02 Million CAD | 0.02% |
2022 FY | 2.13 Million CAD | 5.46% |
2022 Q3 | 2.13 Million CAD | 4.27% |
2021 Q1 | - CAD | 0.0% |
2021 FY | 2.02 Million CAD | 0.0% |
2021 Q4 | 2.02 Million CAD | 0.0% |
2021 Q3 | - CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 FY | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2017 Q1 | - CAD | -100.0% |
2017 Q4 | - CAD | 0.0% |
2017 FY | - CAD | -100.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2016 FY | 190.27 Thousand CAD | 0.0% |
2016 Q4 | 190.27 Thousand CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
BioMark Diagnostics Inc. | 805.93 Thousand CAD | -155.157% |
Sona Nanotech Inc. | 527.68 Thousand CAD | -289.703% |